Search results
Results From The WOW.Com Content Network
Enterobacter cloacae is a member of the normal gut flora of many humans and is not usually a primary pathogen. [9] Some strains have been associated with urinary tract and respiratory tract infections in immunocompromised individuals.
Enterobacter cloacae: General distribution Enterococcus spp Mouth, GI tract Enterococcus faecalis: General distribution Enterococcus faecium: General distribution Escherichia coli: General distribution Eubacterium spp Mouth, GI tract Faecalibacterium spp Large intestine, small intestine (Ileon) Flavobacterium spp Large intestine, small ...
Carbapenem-resistant Enterobacteriaceae (CRE) have been defined as carbapenem-nonsusceptible and extended-spectrum cephalosporin-resistant Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or Klebsiella oxytoca. Some exclude ertapenem resistance from the definition. [5]
A 2012 study has shown that the presence of Enterobacter cloacae B29 in the gut of a morbidly obese individual may have contributed to the patient's obesity. Reduction of the bacterial load within the patient's gut, from 35% E. cloacae B29 to non-detectable levels, was associated with a parallel reduction in endotoxin load in the patient and a ...
Enterobacteriaceae is a large family of Gram-negative bacteria.It includes over 30 genera and more than 100 species. Its classification above the level of family is still a subject of debate, but one classification places it in the order Enterobacterales of the class Gammaproteobacteria in the phylum Pseudomonadota.
ESKAPE is an acronym comprising the scientific names of six highly virulent and antibiotic resistant bacterial pathogens including: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. [1] The acronym is sometimes extended to ESKAPEE to include Escherichia coli. [2]
Klebsiella aerogenes, [2] previously known as Enterobacter aerogenes, is a Gram-negative, oxidase-negative, catalase-positive, citrate-positive, indole-negative, rod-shaped bacterium. [3] Capable of motility via peritrichous flagella, [4] it is approximately one to three microns in length.
Fosfomycin was discovered in 1969 and approved for medical use in the United States in 1996 [globalize] [8] [10] It is on the World Health Organization's List of Essential Medicines. [11] The World Health Organization classifies fosfomycin as critically important for human medicine. [12] It is available as a generic medication. [13]